112 related articles for article (PubMed ID: 2998325)
1. Polysubstrate monooxygenases in Drosophila, mammals and man.
Würgler FE
Basic Life Sci; 1985; 34():157-82. PubMed ID: 2998325
[TBL] [Abstract][Full Text] [Related]
2. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
[TBL] [Abstract][Full Text] [Related]
3. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.
Robertson IG; Zeiger E; Goldstein JA
Carcinogenesis; 1983; 4(1):93-6. PubMed ID: 6295661
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies on the metabolism of aflatoxin B1 and aldrin in testes of genetically different strains of Drosophila melanogaster.
Foerster RE; Würgler FE
Arch Toxicol; 1984 Nov; 56(1):12-7. PubMed ID: 6440510
[TBL] [Abstract][Full Text] [Related]
5. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
Ishii K; Maeda K; Kamataki T; Kato R
Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of aflatoxin B1 activation in rat hepatoma cells.
Corcos L; Rousset JP; Kiefer F; Wiebel FJ; Weiss MC
Mol Gen Genet; 1990 Jul; 222(2-3):291-6. PubMed ID: 2125692
[TBL] [Abstract][Full Text] [Related]
8. Interrelationships in mice of antipyrine half-life, hepatic monooxygenase activities and liver S9-mediated mutagenicity of aflatoxin B1, benzo[alpha]pyrene 7,8-dihydrodiol, 2-acetylaminofluorene and N-nitrosomorpholine.
Roberfroid MB; Malaveille C; Hautefeuille A; Brun G; Vo TK; Bartsch H
Chem Biol Interact; 1983 Nov; 47(2):175-94. PubMed ID: 6418395
[TBL] [Abstract][Full Text] [Related]
9. Activation and inactivation of a variety of mutagenic compounds by the reconstituted system containing highly purified preparations of cytochrome P-450 from rat liver.
Kawano S; Kamataki T; Maeda K; Kato R; Nakao T; Mizoguchi I
Fundam Appl Toxicol; 1985 Jun; 5(3):487-98. PubMed ID: 3924696
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody-directed analysis of cytochrome P-450-dependent monooxygenases and mutagen activation in the livers of DBA/2 and C57BL/6 mice.
Hietanen E; Malaveille C; Friedman FK; Park SS; Béréziat JC; Brun G; Bartsch H; Gelboin HV
Cancer Res; 1986 Feb; 46(2):524-31. PubMed ID: 3510075
[TBL] [Abstract][Full Text] [Related]
11. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
Shimada T; Nakamura S; Imaoka S; Funae Y
Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
[TBL] [Abstract][Full Text] [Related]
12. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin B1.
Ueno Y; Ishii K; Omata Y; Kamataki T; Kato R
Carcinogenesis; 1983 Aug; 4(8):1071-3. PubMed ID: 6409444
[TBL] [Abstract][Full Text] [Related]
13. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
Raina V; Williams CJ; Gurtoo HL
Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the continuous rat hepatoma cell line 2sFou with primary rat hepatocyte cultures for the induction of DNA repair synthesis by nitrosamines, benzo[a]pyrene and hydroxyurea.
Rossberger S; Andrae U; Wiebel FJ
Mutat Res; 1987 Feb; 182(1):41-51. PubMed ID: 3807938
[TBL] [Abstract][Full Text] [Related]
15. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man.
Mori Y; Yamazaki H; Toyoshi K; Maruyama H; Konishi Y
Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034
[TBL] [Abstract][Full Text] [Related]
16. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
[No Abstract] [Full Text] [Related]
17. Activation of the hepatocarcinogen aflatoxin B1 by forms of human hepatic cytochromes P-450: some do and some don't.
Bonkovsky HL
Hepatology; 1991 May; 13(5):1003-5. PubMed ID: 1903123
[No Abstract] [Full Text] [Related]
18. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: implications for human biotransformation enzyme polymorphisms.
Eaton DL; Bammler TK; Kelly EJ
Adv Exp Med Biol; 2001; 500():559-76. PubMed ID: 11764998
[TBL] [Abstract][Full Text] [Related]
19. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
Guobaitis RJ; Ellingham TJ; Maddock MB
Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of chemical carcinogens.
Dipple A; Michejda CJ; Weisburger EK
Pharmacol Ther; 1985; 27(3):265-96. PubMed ID: 3931106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
